Company: MIRM
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001759425-25-000022
Chunk: 70

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 70
---
 and officer of BVF Inc., may be deemed to beneficially own the 3,075,907 shares of common stock beneficially owned by BVF Inc. The foregoing should not be construed in and of itself as an admission by any such person as to beneficial ownership of any shares of common stock owned by another such person. BVF GP disclaims beneficial ownership of the shares of common stock beneficially owned by BVF. BVF2 GP disclaims beneficial ownership of the shares of common stock beneficially owned by BVF2. Partners OS disclaims beneficial ownership of the shares of common stock beneficially owned by Trading Fund OS. BVF GPH disclaims beneficial ownership of the shares of common stock beneficially owned by BVF and BVF2. Each of Partners, BVF Inc. and Mr. Lampert disclaims beneficial ownership of the shares of common stock beneficially owned by BVF, BVF2 and Trading Fund OS and held in the Partners Managed Account, and the filing of this statement shall not be construed as an admission that any such person or entity is the beneficial owner of any such securities. The address of BVF, BVF GP, BVF2, BVF2 GP, BVF GPH, Partners and Mr. Lampert is 44 Montgomery St., 40th Floor, San Francisco, California 94104. The address of Trading Fund OS and Partners OS is PO Box 309 Ugland House, Grand Cayman, KY1-1104, Cayman Islands. The foregoing information was obtained from a Schedule 13G/A filed on November 14, 2024.

(5) Consists of 2,606,938 shares of common stock directly held by Eventide Asset Management, LLC ( “Eventide” ) and indirectly held by Finny Kuruvilla, M.D. Ph. D. and Robin C. John as of December 31, 2024. Mr. John is the Chief Executive Officer of Eventide and Dr. Kuruvilla is a Co-Chief Investment Officer, Senior Portfolio Manager and Managing Director of Eventide. The address of Eventide, Mr. Robin and Dr. Kuruvilla is One International Place, Suite 4210, Boston, Massachusetts 02110. The foregoing information was obtained from a Schedule 13G/A filed on February 14, 2025, except that the relationship of Mr. Robin and Dr. Kuruvilla to Eventide was not included in such Schedule 13G/A and was obtained from